Immunohaematological and apheretic aspects of the first kidney transplant from a living, ABO-incompatible donor carried out in Italy

Blood Transfusion

Volumn 9, Issue 2, 2011, Pages 218-224

  Sassi, Maria ^a   Maggiore, Umberto ^a   Buzio, Carlo ^a   Franchini, Massimo ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

ADULT; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CASE REPORT; DIALYSIS; DRUG DOSE REDUCTION; HUMAN; IMMUNE RESPONSE; ITALY; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; SINGLE DRUG DOSE;

ABO BLOOD-GROUP SYSTEM; AGED; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; HUMANS; ITALY; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 79953720031     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2010.0013-10     Document Type: Article

References (39)

1. Breimer ME, Molne J, Norden G, et al. Blood group A and B antigen expression in human kidneys correlated to A1/A2/B, Lewis, and secretor status. Transplantation 2006; 82: 479.
2. Karpinski M, Knoll G, Cohon A, et al. The impact of accepting living kidney donors with mild hypertension or proteinuria on transplantation rates. Am J Kidney Dis 2005; 47: 317-23. (Pubitemid 43121335)
3. Report Annuale Centro Nazionale Trapianti 2009. Available at http://www.trapianti.ministerosalute.it.
4. Park K, Moon J, Kim S, et al. Exchange donor program in kidney transplantation. Transplantation 1999; 67: 336-8. (Pubitemid 29066366)
5. Delmonico FL, Morrissey PE, Lipkowitz GS, et al. Donor kidney exchanges. Am J Transplant 2004; 4: 1628-34. (Pubitemid 39312296)
6. de Klerk M, Witvliet MD, Haase-Kromwijk BJ, et al. A highly efficient living donor kidney exchange program for both blood type and crossmatch incompatible donor-recipient combinations. Transplantation 2006; 82: 1616-20. (Pubitemid 46035638)
7. Terasaki PI, Gjertson DW, Cecka JM. Paired kidney exchange is not a solution to ABO incompatibility. Transplantation 1998; 65: 291.
8. Ross LF, Zenios S. Practical and ethical challenges to paired exchange programs. Am J Transplant 2004; 4: 1553-4. (Pubitemid 39312287)
9. Gentry SE, Segev DL, Montgomery RA. A comparison of populations served by kidney paired donation and list paired donation. Am J Transplant 2005; 5: 1914-21. (Pubitemid 41039865)
10. Genberg H, Kumlien G, Wennberg L, et al. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up. Transplantation 2008; 85: 1745-54.
11. Alexandre GPJ, Squifflet JP, De Bruyère M, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985; 17: 138.
12. Takahashi K, Saito K, Takahara S, et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089-96. (Pubitemid 38868599)
13. Tanabe K, Takahashi K, Sonda K, et al. Long-term results ABO-incompatible living kidney transplantation: a single experience. Transplantation 1998; 65: 224-8. (Pubitemid 28101328)
14. Ichimaru N, Takahara S. Japan's experience with living-donor kidney transplantation across ABO barriers. Nat Clin Pract Nephrol 2008; 4: 682-92.
15. Sonnenday CJ, Warren DS, Cooper M, et al. Plasmapheresis, CMV hyperimmune globulin, and anti-CD-20 allow ABO renal transplantation without splenectomy. Am J Transplant 2004; 4: 1315-22. (Pubitemid 39013579)
16. Gloor JM, Lager DJ, Fidler ME, et al. A comparison of splenectomy versus intensive posttransplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation. Transplantation 2005; 80: 1572-7. (Pubitemid 43005868)
17. Segev DL, Simpkins CE, Warren DS, et al. ABO incompatible high-titre renal transplantation without splenectomy or anti-CD20 treatment. Am J Transplant 2005; 5: 2570-5.
18. Montgomery RA, Locke JE, King KE, et al. ABO incompatible renal transplantation: a paradigm ready for broad implementation. Transplantation 2009; 87: 1246.
19. Winters JL, Gloor JM, Pineda AA, et al. Plasma exchange conditioning for ABO-incompatible renal transplantation. J Clin Aphereresis 2004; 19: 79-85. (Pubitemid 39006612)
20. Tyden G, Kumlien G, Genberg H, et al. ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 2005; 5: 145-8. (Pubitemid 40095139)
21. Kumlien G, Ullstrom L, Losvall A, et al. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies. Transfusion 2006; 46: 1568-75. (Pubitemid 44326333)
22. Tyden G, Donauer J, Wadstrom J, et al. Implementation of a protocol for ABO-incompatible kidney transplantation - a three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153-5. (Pubitemid 46743673)
23. Wilpert J, Geyer M, Teschner S, et al. ABO-incompatible kidney transplantation- proposal of an intensified apheresis strategy for patients with high initial isoagglutinine titers. J Clin Apheresis 2007; 22: 314-22. (Pubitemid 351219765)
24. Oettl T, Halter J, Bachmann A, et al. ABO blood group-incompatible living donor kidney transplantation: a prospective, single-center analysis including serial protocol biopsies. Nephrol Dial Transplant 2009; 24: 298-303.
25. Wilpert J, Geyer M, Pisarski P, et al. On demand strategy as an alternative to conventionally scheduled post-transplant immunoadsorptions after ABO-incompatible kidney transplantation. Nephrol Dial Transplant 2007; 22: 3048-51. (Pubitemid 350093468)
26. Crew RJ, Ratner LE. ABO-incompatible transplantation: current practice and the decade ahead. Curr Opin Organ Transplant 2010; 15: 526-30.
27. Tanabe K. Double-filtration plasmapheresis. Transplantation 2007; 84: S30-S32.
28. The British Transplantation Society Guidelines for Antibody Incompatible Transplantation, 2006. Available at www.bts.org.uk.
29. Valli PV, Puga Yung G, Fehr TV, et al. Changes of circulating antibody levels induced by ABO antibody adsorption for ABO-incompatible kidney transplantation. Am J Transplant 2009; 9: 1072-80.
30. Tobian AA, Shirey RS, Montgomery RA, et al. The critical role of plasmapheresis in ABO-incompatible renal transplantation. Transfusion 2008; 48: 2453-60.
31. Tanabe K. Interinstitutional variation in the measurement of anti-A/B antibodies: the Japanese ABO-Incompatible Transplantation Committee Survey. Transplantation 2007; 84: S13-6.
32. Kumlien G, Wilpert J, Safwenberg J, et al. Comparing the tube test and gel techniques for ABO antibody titration, as performed in three European centers. Transplantation 2007; 84: S17-9.
33. AuBuchon JP, de Widt-Eggen J, Dumont J. Reducing variation in performance of antibody titrations. Vox Sang 2008; 95: 57-65. (Pubitemid 351799409)
34. Shirey RS, Cai W, Montgomery RA, et al. Streamlining ABO antibody titrations for monitoring ABO-incompatible kidney transplants. Transfusion 2010; 50: 631-4.
35. Krishnan NS, Fleetwood P, Higgins RM, et al. Application of flow cytometry to monitor antibody levels in ABO incompatible kidney transplantation. Transplantation 2008; 86: 474-7.
36. Park WD Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003; 3: 952-60.
37. Aljeidai AH. Cost analysis of renal transplantation in highly sensitized recipients compared to maintenance hemodialysis. Am J Transplant 2008; 8(S2): 180 (Abstr 7).
38. Schwartz J. Complications, resource utilization, and cost of ABO incompatible living donor kidney transplantation Transplantation 2006; 82: 155-63.
39. Schnitzler M. ABO-incompatible living donor transplantation: is it economically "compatible"? Transplantation 2006; 82: 168-9.